COVID-19 Notice

Please note, our business hours have not changed. As we navigate through the Coronavirus Pandemic, our office will continue to be responsive to all inquiries during our normal business hours. If you need to reach a doctor during non-business hours, please call 201-692-9434 and follow the emergency contact instructions. You can reach us by phone at 201-692-9434 or e-mail at

Glenpoint Centre East 300 Frank W. Burr Blvd. Teaneck, New Jersey, 07666



Intracorneal ring segments (Intacs) may be used as an additive procedure to corneal collagen crosslinking for keratoconus (CXL).  The two procedures have different goals.  Intacs acts to reshape the cornea, flattening the cone and improving the corneal optics.  The goal of CXL is to decrease the progression of keratoconus.  Depending on your condition, we may recommend these procedures for you. 

For patients having both the Intacs and CXL procedure, first the channel for the Intacs is created with the femtosecond laser. Next, the surface epithelial cells of the cornea are removed and riboflavin drops are administered until they fully soak into the cornea.  After we are sure that the riboflavin is completed distributed within the cornea, the ultraviolet light portion of the procedure begins.  The patient then looks at a UV emitting light.  During that time, we continue to administration riboflavin drops. At the conclusion of the CXL procedure, the Intacs are placed within the previously prepared channels. Antibiotic and anti-inflammatory drops are used for two weeks afterward.


Study closed - Intacs/CXL is available for treatment outside of clinical trials 

We are currently enrolling patients in a clinical study looking at the effectiveness of combined Intacs and corneal collagen crosslinking (CXL) in patients with either keratoconus or corneal ectasia after previous LASIK. This trial will evaluate the benefits and safety of a combined Intacs and CXL procedure. The second objective of the study is to compare the timing of the 2 procedures on clinical outcomes.
For further information and inquiries about this Keratoconus crosslinking study, please call 201-883-0505 or email

For further qualifications and information, please click below: